Búsqueda Imágenes Maps Play YouTube Noticias Gmail Drive Más »
Iniciar sesión
Usuarios de lectores de pantalla: deben hacer clic en este enlace para utilizar el modo de accesibilidad. Este modo tiene las mismas funciones esenciales pero funciona mejor con el lector.

Patentes

  1. Búsqueda avanzada de patentes
Número de publicaciónUS20070123961 A1
Tipo de publicaciónSolicitud
Número de solicitudUS 11/617,512
Fecha de publicación31 May 2007
Fecha de presentación28 Dic 2006
Fecha de prioridad12 Nov 2004
También publicado comoCA2941003A1, EP2902069A1, US8920413, US20060247617, US20070093802, US20070112349, US20170135758
Número de publicación11617512, 617512, US 2007/0123961 A1, US 2007/123961 A1, US 20070123961 A1, US 20070123961A1, US 2007123961 A1, US 2007123961A1, US-A1-20070123961, US-A1-2007123961, US2007/0123961A1, US2007/123961A1, US20070123961 A1, US20070123961A1, US2007123961 A1, US2007123961A1
InventoresChristopher Danek, Gary Kaplan, William Wizeman, Michael Laufer
Cesionario originalAsthmax, Inc.
Exportar citaBiBTeX, EndNote, RefMan
Enlaces externos: USPTO, Cesión de USPTO, Espacenet
Energy delivery and illumination devices and methods
US 20070123961 A1
Resumen
This relates to methods and devices for improving treatment to a wall, a cavity or passageway with a medical device when used in tortuous anatomy.
Imágenes(19)
Previous page
Next page
Reclamaciones(28)
1. A method for differentiating treated tissue from untreated tissue in an airway of a human lung, the method comprising:
delivering energy to tissue of an airway of a lung so as to treat asthma; and
illuminating the tissue so as to differentiate treated tissue from untreated tissue.
2. The method of claim 1, wherein illuminating comprises emitting light at certain wavelengths.
3. The method of claim 2, wherein the certain wavelengths include 470 nm, 570 nm, or 590 nm.
4. The method of claim 1, wherein illuminating comprises emitting light at a single wavelength or multiple wavelengths.
5. The method of claim 1, wherein illuminating comprises emitting light in a visible, ultraviolet, infrared, or non-visible spectrum.
6. The method of claim 5, further comprising filtering the light.
7. The method of claim 1, wherein illuminating the tissue comprises emitting light through a polarizing filter or fiber so as to differentiate treated tissue from untreated tissue based on birefringence.
8. The method of claim 7, wherein the polarized light is reflected or transmitted.
9. The method of claim 7, wherein delivering energy to tissue comprises heating the tissue such that the tissue loses an ability to polarize light.
10. The method of claim 1, wherein illuminating the tissue so as to differentiate treated tissue from untreated tissue is based on reflectance of the tissue.
11. A method for differentiating treated tissue from untreated tissue in an airway of a human lung, the method comprising:
delivering energy to tissue of an airway of a lung so as to treat asthma; and
filtering tissue images from a bronchoscopic visualization system so as to differentiate treated tissue from untreated tissue.
12. The method of claim 11, wherein filtering comprises electronically filtering the tissue images for desired wavelengths.
13. An energy delivery and illumination device for use within an airway of a human lung, the device comprising:
an elongate shaft having a proximal portion and a distal portion;
a plurality radio frequency electrodes disposed at the distal portion of the shaft, the electrodes being configured to contact a lung airway wall in an expanded radial configuration and apply energy to treat asthma; and
an illumination source located towards the distal portion of the shaft.
14. The device of claim 13, wherein the illumination source is coupled to the distal portion of the shaft.
15. The device of claim 13, wherein the illumination source is coupled to one of the electrodes.
16. The device of claim 13, further comprising a distal tip coupled to distal ends of the electrodes.
17. The device of claim 16, wherein the illumination source is coupled to the distal tip.
18. The device of claim 16, further comprising a center wire extending from the proximal portion of the shaft to the distal tip, wherein the illumination source is coupled to the center wire.
19. The device of claim 13, wherein the illumination source comprises a plurality of illumination sources.
20. The device of claim 13, wherein the illumination source comprises a light emitting diode.
21. The device of claim 13, wherein the illumination source comprises an optical fiber or filament.
22. The device of claim 13, further comprising a filter located towards the distal portion of the shaft.
23. An energy delivery and illumination system comprising:
the device of claim 13;
a source of energy electrically coupled to the electrodes for the delivery of monopolar or bipolar radio frequency energy.
24. The system of claim 23, further comprising an illumination supply coupled to the illumination source for emitting light.
25. The system of claim 24, wherein the illumination supply comprises a coherent light source.
26. The system of claim 25, wherein the coherent light source comprises a laser.
27. The system of claim 23, further comprising a bronchoscope having a working channel for slidably receiving the device.
28. The system of claim 27, further comprising a filter coupled to the bronchoscope.
Descripción
    CROSS-REFERENCE TO RELATED APPLICATIONS
  • [0001]
    This application is a continuation of U.S. patent application Ser. No. 11/420,407, filed May 25, 2006, which is a continuation of PCT Application No. PCT/US2005/041243, filed Nov. 14, 2005, which claims benefit to U.S. Provisional Patent Application No. 60/627,662, filed Nov. 12, 2004 and U.S. patent application Ser. No. 11/255,796, filed Oct. 21, 2005, the contents of each of which are incorporated herein by reference in their entirety.
  • BACKGROUND OF THE INVENTION
  • [0002]
    Asthma is a disease in which (i) bronchoconstriction, (ii) excessive mucus production, and (iii) inflammation and swelling of airways occur, causing widespread but variable airflow obstruction thereby making it difficult for the asthma sufferer to breathe. Asthma is a chronic disorder, primarily characterized by persistent airway inflammation. However, asthma is further characterized by acute episodes of additional airway narrowing via contraction of hyper-responsive airway smooth muscle.
  • [0003]
    Asthma is managed pharmacologically by: (1) long term control through use of anti-inflammatories and long-acting bronchodilators and (2) short term management of acute exacerbations through use of short-acting bronchodilators. Both of these approaches require repeated and regular use of the prescribed drugs. High doses of corticosteroid anti-inflammatory drugs can have serious side effects that require careful management. In addition, some patients are resistant to steroid treatment. The difficulty involved in patient compliance with pharmacologic management and the difficulty of avoiding stimulus that triggers asthma are common barriers to successful asthma management.
  • [0004]
    Current management techniques are neither completely successful nor free from side effects. Presently, a new treatment for asthma is showing promise. This treatment comprises the application of energy to the airway smooth muscle tissue. Additional information about this treatment may be found in commonly assigned patents and applications in U.S. Pat. Nos. 6,411,852, 6,634,363 and U.S. published application nos. US-2005-0010270-A1 and US-2002-0091379-A1, the entirety of each of which is incorporated by reference.
  • [0005]
    The application of energy to airway smooth muscle tissue, when performed via insertion of a treatment device into the bronchial passageways, requires navigation through tortuous anatomy as well as the ability to treat a variety of sizes of bronchial passageways. As discussed in the above referenced patents and applications, use of an RF energy delivery device is one means of treating smooth muscle tissue within the bronchial passageways.
  • [0006]
    FIG. 1A illustrates a bronchial tree 90. As noted herein, devices treating areas of the lungs must have a construction that enables navigation through the tortuous passages. As shown, the various bronchioles 92 decrease in size and have many branches as they extend into the right and left bronchi 94. Accordingly, an efficient treatment requires devices that are able to treat airways of varying sizes as well as function properly when repeatedly deployed after navigating through the tortuous anatomy.
  • [0007]
    Tortuous anatomy also poses challenges when the treatment device requires mechanical actuation of the treatment portion (e.g., expansion of a treatment element at a remote site). In particular, attempting to actuate a member may be difficult in view of the fact that the force applied at the operator's hand-piece must translate to the distal end of the device. The strain on the operator is further intensified given that the operator must actuate the distal end of the device many times to treat various portions of the anatomy. When a typical device is contorted after being advanced to a remote site in the lungs, the resistance within the device may be amplified given that internal components are forced together.
  • [0008]
    It is also noted that the friction of polymers is different from that of metals. Most polymers are viscoelastic and deform to a greater degree under load than metals. Accordingly, when energy or force is applied to move two polymers against each other, a significant part of friction between the polymers is the energy loss through inelastic hysteresis. In addition, adhesion between polymers also plays a significant part in the friction between such polymers.
  • [0009]
    In addition to basic considerations of navigation and site access, there exists the matter of device orientation and tissue contact at the treatment site. Many treatment devices make contact or are placed in close proximity to the target tissue. Yet, variances in the construction of the treatment device may hinder proper alignment or orientation of the device. For example, in the case of a device having a basket-type energy transfer element that is deployed intralumenally, the treatment may benefit from uniform contact of basket elements around the perimeter of the lumen. However, in this case, design or manufacturing variances may tend to produce a device where the angle between basket elements is not uniform. This problem tends to be exacerbated after repeated actuation of the device and/or navigating the device through tortuous anatomy when the imperfections of the device become worsened through plastic deformation of the individual components. Experience demonstrates that once a member becomes predisposed to splaying (i.e., not maintaining the desired angular separation from an adjacent element), or inverting (i.e., buckling inward instead of deploying outward), the problem is unlikely to resolve itself without requiring attention by the operator. As a result, the operator is forced to remove the device from the patient, make adjustments, and then restart treatment. This interruption tends to increase the time of the treatment session.
  • [0010]
    As one example, commonly assigned U.S. Pat. No. 6,411,852, incorporated by reference herein, describes a treatment for asthma using devices having flexible electrode members that can be expanded to better fill a space (e.g., the lumen of an airway.) However, the tortuous nature of the airways was found to cause significant bending and/or flexure of the distal end of the device. As a result, the spacing of electrode members tended not to be even. In some extreme cases, electrode elements could tend to invert, where instead of expanding an electrode leg would invert behind an opposing leg.
  • [0011]
    For many treatment devices, the distortion of the energy transfer elements might cause variability in the treatment effect. For example, many RF devices heat tissue based on the tissue's resistive properties. Increasing or decreasing the surface contact between the electrode and tissue often increases or decreases the amount of current flowing through the tissue at the point of contact. This directly affects the extent to which the tissue is heated. Similar concerns may also arise with resistive heating elements, devices used to cool the airway wall by removing heat, or any energy transfer device. In any number of cases, variability of the energy transfer/tissue interface causes variability in treatment results. The consequential risks range from an ineffective treatment to the possibility of patient injury.
  • [0012]
    Furthermore, most medical practitioners recognize the importance of establishing acceptable contact between the transfer element and tissue. Therefore, distortion of the transfer element or elements increases the procedure time when the practitioner spends an inordinate amount of time adjusting a device to compensate for or avoid such distortion. Such action becomes increasingly problematic in those cases where proper patient management limits the time available for the procedure.
  • [0013]
    For example, if a patient requires an increasing amount of medication (e.g., sedatives or anesthesia) to remain under continued control for performance of the procedure, then a medical practitioner may limit the procedure time rather than risk overmedicating the patient. As a result, rather than treating the patient continuously to complete the procedure, the practitioner may plan to break the procedure in two or more sessions. Subsequently, increasing the number of sessions poses additional consequences on the part of the patient in cost, the residual effects of any medication, adverse effects of the non-therapeutic portion of the procedure, etc.
  • [0014]
    In addition to the above, because the procedure is generally performed under direct visualization via a scope-type device, it may be desirable for a medical practitioner to directly observe the treatment areas so that the next adjacent area of tissue may be treated while minimizing overlap between treatment areas. Alternatively, or in combination, the medical practitioner may advance a device out of the bronchoscope into distal airways where visualization is difficult because the scope's light source is insufficient or blocked. Accordingly, there remains a need to provide a device that supplements the illumination provided by the scope, or illuminates the airway with a light of a particular wavelength that allows the practitioner to better observe the treatment area.
  • [0015]
    In view of the above, the present methods and devices described herein provide an improved means for treating tortuous anatomy such as the bronchial passages. It is noted that the improvements of the present device may be beneficial for use in other parts of the anatomy as well as the lungs.
  • SUMMARY OF THE INVENTION
  • [0016]
    The present invention includes devices configured to treat the airways or other anatomical structures, and may be especially useful in tortuous anatomy. The devices described herein are configured to treat with uniform or predictable contact (or near contact) between an active element and tissue. Typically, the invention allows this result with little or no effort by a physician. Accordingly, aspects of the invention offer increased effectiveness and efficiency in carrying out a medical procedure. The increases in effectiveness and efficiency may be especially apparent in using devices having relatively longer active end members.
  • [0017]
    In view of the above, a variation of the invention includes a catheter for use with a power supply, the catheter comprising a flexible elongate shaft coupled to at least one energy transfer element that is adapted to apply energy to the body lumen. The shaft will have a flexibility to accommodate navigation through tortuous anatomy. The energy transfer elements are described below and include basket type design, or other expandable designs that permit reduction in size or profile to aid in advancing the device to a particular treatment site and then may be expanded to properly treat the target site. The basket type designs may be combined with expandable balloon or other similar structures.
  • [0018]
    Variations of the device can include an elongate sheath having a near end, a far end adapted for insertion into the body, and having a flexibility to accommodate navigation through tortuous anatomy, the sheath having a passageway extending therethrough, the passageway having a lubricious layer extending from at least a portion of the near end to the far end of the sheath. Where the shaft is slidably located within the passageway of the sheath.
  • [0019]
    Variations of devices described herein can include a connector for coupling the energy transfer element to the power supply. The connector may be any type of connector commonly used in such applications. Furthermore, the connector may include a cable that is hard-wired to the catheter and connects to a remote power supply. Alternatively, the connector may be an interface that connects to a cable from the power supply.
  • [0020]
    As noted below, variations of the device allow for reduce friction between the shaft and sheath to allow relatively low force advancement of a distal end of the shaft out of the far end of the sheath for advancement the energy transfer element.
  • [0021]
    Additional variations of the invention include devices allowing for repeatable deployment of the expandable energy transfer element while maintaining the orientation and/or profile of the components of the energy transfer element. One such example includes an energy transfer basket comprising a plurality of legs, each leg having a distal end and a proximal end, each leg having a flexure length that is less than a full length of the leg. The legs are coupled to near and far alignment components. The near alignment component includes a plurality of near seats extending along an axis of the alignment component. The near alignment component can be secured to the elongate shaft of the device. The far alignment component may have a plurality of far seats extending along an axis of the alignment component, where the plurality of near seats are in alignment with the plurality of far seats. In these variations of the device, each distal end of each leg is nested within a far seat of the far alignment component and each proximal end of each leg is nested within a near seat of the near alignment component such that an angle between adjacent legs is determined by an angle between adjacent near seats and the flexure length of each length is determined by the distance between near and far alignment components.
  • [0022]
    One or both of the components may include stops that control flexure length of each leg. Such a design increases the likelihood that the flexure of each leg is uniform.
  • [0023]
    An additional variation of the device includes a catheter for use in tortuous anatomy to deliver energy from a power supply to a body passageway. Such a catheter includes an expandable energy transfer element having a reduced profile for advancement and an expanded profile to contact a surface of the body passageway and an elongate shaft having a near end, a far end adapted for insertion into the body, the expandable energy transfer element coupled to the far end of the shaft, the shaft having a length sufficient to access remote areas in the anatomy. The design of this shaft includes a column strength sufficient to advance the expandable energy transfer element within the anatomy, and a flexibility that permits self-centering of the energy transfer element when expanded to contact the surface of the body passageway.
  • [0024]
    In a further variation of the invention, the device and/or system may include an illumination source and/or supply. The illumination source may be configured to provide a single or multiple wavelength of light depending upon the particular application. For example, the device may be configured to provide illumination that is visible light, or white light. The illumination can be a single visible color such as red, green, blue, yellow, or a combination. The illumination may be a non-visible wavelength that is made visible by some type of filter or other such means on the scope or viewing monitor for the scope.
  • [0025]
    When tissue, in particular airway wall tissue, is heated as a result of treatment, collagen fibers within the tissue loose their organization. As a result, the ability to polarize transmitted and reflected light is altered. In some cases, depending on temperature, the polarization axis changes. This is a so-called change in birefringence. In certain cases, tissue heated to a sufficiently high temperature may lose the ability to polarize light. Therefore, the illumination may be suited to view areas of heated collagen fibers so as to identify treated tissue (e.g., with the procedures described in the patents discussed above and U.S. Pat. No. 6,634,363, US publication 20020091379A1 both of which are incorporated by reference). Various wavelengths (including but not limited to wavelengths in the infrared, ultraviolet, as well as visible spectrum) of the illumination source and/or filters may be used so that the medical practitioner may identify the treated tissue.
  • [0026]
    In addition, certain wavelengths may afford separation from red and orange (e.g., 590 nm, 570 nm, 470 nm or yellow, green, and blue.) These colors may offer better distinction when used in airways.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • [0027]
    Each of the following figures diagrammatically illustrates aspects of the invention. Variation of the invention from the aspects shown in the figures is contemplated.
  • [0028]
    FIG. 1 is an illustration of the airways within a human lung.
  • [0029]
    FIG. 2A is a schematic view of an exemplary system for delivering energy according to the present invention.
  • [0030]
    FIG. 2B is a side view of a device extending out of an endoscope/bronchoscope, where the device has an active distal end for treating tissue using energy delivery.
  • [0031]
    FIGS. 3A-3G show various features of the device allowing for low force deployment of the energy element.
  • [0032]
    FIGS. 4A-4C illustrate various alignment components of the device.
  • [0033]
    FIGS. 4D-4E demonstrate the alignment components coupled to a leg of the device.
  • [0034]
    FIGS. 4F-4H illustrate an additional variation of an alignment component.
  • [0035]
    FIGS. 5A-5B is a variation of an energy transfer element according to the present device.
  • [0036]
    FIGS. 5C-5D show variations in which the legs of the device are biased to expand outward.
  • [0037]
    FIGS. 6A-6C show various basket configurations for the device.
  • [0038]
    FIGS. 7A-7D illustrate various features of variations of legs for use with the present devices.
  • [0039]
    FIGS. 8A-8D show various junctions for use with the present devices to improve alignment when the device is advanced through tortuous anatomy.
  • [0040]
    FIGS. 9A-9J are addition variations of junctions.
  • [0041]
    FIGS. 10A-10D shows additional variations of junctions for use in the present devices.
  • [0042]
    FIGS. 11A-11C shows additional variations of systems and devices using illumination.
  • DETAILED DESCRIPTION
  • [0043]
    It is understood that the examples below discuss uses in the airways of the lungs. However, unless specifically noted, the invention is not limited to use in the lung. Instead, the invention may have applicability in various parts of the body. Moreover, the invention may be used in various procedures where the benefits of the device are desired.
  • [0044]
    FIG. 2A shows a schematic diagram of one example of a system 10 for delivering therapeutic energy to tissue of a patient for use with the device described herein. The illustrated variation shows, the system 10 having a power supply (e.g., consisting of an energy generator 12, a controller 14 coupled to the energy generator, a user interface surface 16 in communication with the controller 14). It is noted that the device may be used with a variety of systems (having the same or different components). For example, although variations of the device shall be described as RF energy delivery devices, variations of the device may include resistive heating systems, infrared heating elements, microwave energy systems, focused ultrasound, cryo-ablation, or any other energy deliver system. It is noted that the devices described should have sufficient length to access the tissue targeted for treatment. For example, it is presently believed necessary to treat airways as small as 3 mm in diameter to treat enough airways for the patient to benefit from the described treatment (however, it is noted that the invention is not limited to any particular size of airways and airways smaller than 3 mm may be treated). Accordingly, devices for treating the lungs must be sufficiently long to reach deep enough into the lungs to treat these airways. Accordingly, the length of the sheath/shaft of the device that is designed for use in the lungs should preferably be between 1.5-3 ft long in order to reach the targeted airways.
  • [0045]
    The particular system 10 depicted in FIG. 2A is one having a user interface as well as safety algorithms that are useful for the asthma treatment discussed above. Addition information on such a system maybe found in U.S. Provisional application No.: 60/674,106, filed Apr. 21, 2005 entitled CONTROL METHODS AND DEVICES FOR ENERGY DELIVERY, the entirety of which is incorporated by reference herein.
  • [0046]
    Referring again to FIG. 2A, a variation of a device 100 described herein includes a flexible sheath 102, an elongate shaft 104 (in this example, the shaft extends out from the distal end of the sheath 102), and a handle or other operator interface 106 (optional) secured to a proximal end of the sheath 102. The distal portion of the device 100 includes an energy transfer element 108 (e.g., an electrode, a basket electrode, a resistive heating element, cyroprobe, etc.). Additionally, the device includes a connector 110 common to such energy delivery devices. The connector 110 may be integral to the end of a cable 112 as shown, or the connector 110 may be fitted to receive a separate cable 112. In any case, the device is configured for attachment to the power supply via some type connector 110. The elongate portions of the device 102 and 104 may also be configured and sized to permit passage through the working lumen of a commercially available bronchoscope or endoscope. As discussed herein, the device is often used within an endoscope, bronchoscope or similar device. However, the device may also be advanced into the body with or without a steerable catheter, in a minimally invasive procedure or in an open surgical procedure, and with or without the guidance of various vision or imaging systems.
  • [0047]
    FIG. 2A also illustrates additional components used in variations of the system. Although the depicted systems are shown as RF type energy delivery systems, it is noted that the invention is not limited as such. Other energy delivery configurations contemplated may include or not require some of the elements described below. The power supply (usually the user interface portion 16) shall have connections 20, 28, 30 for the device 100, return electrode 24 (if the system 10 employs a monopolor RF configuration), and actuation pedal(s) 26 (optional). The power supply and controller may also be configured to deliver RF energy to an energy transfer element configured for bipolar RF energy delivery. The user interface 16 may also include visual prompts 32, 60, 68, 74 for user feedback regarding setup or operation of the system. The user interface 16 may also employ graphical representations of components of the system, audio tone generators, as well as other features to assist the user with system use.
  • [0048]
    In many variations of the system, the controller 14 includes a processor 22 that is generally configured to accept information from the system and system components, and process the information according to various algorithms to produce control signals for controlling the energy generator 12. The processor 22 may also accept information from the system 10 and system components, process the information according to various algorithms and produce information signals that may be directed to the visual indicators, digital display or audio tone generator of the user interface in order to inform the user of the system status, component status, procedure status or any other useful information that is being monitored by the system. The processor 22 of the controller 14 may be digital IC processor, analog processor or any other suitable logic or control system that carries out the control algorithms. U.S. Provisional application no. 60/674,106 filed Apr. 21, 2005 entitled CONTROL METHODS AND DEVICES FOR ENERGY DELIVERY the entirety of which is incorporated by reference herein.
  • [0049]
    FIG. 2B illustrates one example of an energy transfer element 108. In this example the energy transfer element 108 is a “basket-type” configuration that requires actuation for expansion of the basket in diameter. Such a feature is useful when the device is operated intralumenally or in anatomy such as the lungs due to the varying size of the bronchial passageways that may require treatment. As illustrated, the basket contains a number of arms 120 which carry electrodes (not shown). In this variation the arms 120 are attached to the elongated shaft 104 at a proximal end while the distal end of the arms 120 are affixed to a distal tip 122. To actuate the basket 108 a wire or tether 124 is affixed to the distal tip 122 to enable compression of the arms 120 between the distal tip 122 and elongate sheath 104.
  • [0050]
    FIG. 2B also illustrates the device 100 as being advanced through a working channel 32 of a bronchoscope 18. While a bronchoscope 18 may assist in the procedure, the device 100 may be used through direct insertion or other insertion means as well.
  • [0051]
    As noted above, some variations of the devices described herein have sufficient lengths to reach remote parts of the body (e.g., bronchial passageways around 3 mm in diameter). FIGS. 3A-3G illustrate various configurations that reduce the force required to actuate the device's basket or other energy transfer element.
  • [0052]
    FIG. 3A illustrates a cross section taken from the sheath 102 and elongate shaft 104. As shown, the sheath 102 includes an outer layer 126 and an inner lubricious layer 128. The outer layer 126 may be any commonly known polymer such as Nylon, PTFE, etc. The lubricious layers 128 discussed herein may comprise a lubricious polymer (for example, HDPE, hydrogel, polytetrafluoroethylene). Typically, lubricious layer 128 will be selected for optimal pairing with the shaft 104. One means to select a pairing of polymers is to maximize the difference in Gibbs surface energy between the two contact layers. Such polymers may also be chose to give the lubricious layer 128 a different modulus of elasticity than the outer layer 126. For example, the modulus of the lubricious layer 128 may be higher or lower than that of the outer layer 126.
  • [0053]
    Alternatively, or in combination, the lubricious layers may comprise a fluid or liquid (e.g., silicone, petroleum based oils, food based oils, saline, etc.) that is either coated or sprayed on the interface of the shaft 104 and sheath 102. The coating may be applied at the time of manufacture or at time of use. Moreover, the lubricious layers 128 may even include polymers that are treated such that the surface properties of the polymer changes while the bulk properties of the polymer are unaffected (e.g., via a process of plasma surface modification on polymer, fluoropolymer, and other materials). Another feature of the treatment is to treat the surfaces of the devices with substances that provide antibacterial/antimicrobial properties.
  • [0054]
    In one variation of the invention, the shaft 104 and/or sheath 102 will be selected from a material to provide sufficient column strength to advance the expandable energy transfer element within the anatomy. Furthermore, the materials and or design of the shaft/sheath will permit a flexibility that allows the energy transfer element to essentially self-align or self-center when expanded to contact the surface of the body passageway. For example, when advanced through tortuous anatomy, the flexibility of this variation should be sufficient that when the energy transfer element expands, the shaft and/or sheath deforms to permit self-centering of the energy transfer element. It is noted that the other material selection and/or designs described herein shall aid in providing this feature of the invention.
  • [0055]
    FIG. 3A also depicts a variation of a shaft 104 for use in the present device. In this variation the shaft 104 includes a corrugated surface 130. It is envisioned that the corrugated surface 130 may include ribbed, textured, scalloped, striated, ribbed, undercut, polygonal, or any similar geometry resulting in a reduced area of surface contact with any adjoining surface(s). The corrugated surface 130 may extend over a portion or the entire length of the shaft 104. In addition, the shape of the corrugations may change at varying points along the shaft 104.
  • [0056]
    The shaft 104 may also include one or more lumens 132, 134. Typically, one lumen will suffice to provide power to the energy transfer elements (as discussed below). However, in the variation show, the shaft may also benefit from additional lumens (such as lumens 134) to support additional features of the device (e.g., temperature sensing elements, other sensor elements such as pressure or fluid sensors, utilizing different lumens for different sensor leads, and fluid delivery or suctioning, etc.). In addition the lumens may be used to deliver fluids or suction fluid to assist in managing the moisture within the passageway. Such management may optimize the electrical coupling of the electrode to the tissue (by, for example, altering impedance). Since the device is suited for use in tortuous anatomy, a variation of the shaft 104 may have lumens 134 that are symmetrically formed about an axis of the shaft. As shown, the additional lumens 134 are symmetric about the shaft 104. This construction provides the shaft 104 with a cross sectional symmetry that aid in preventing the shaft 104 from being predisposed to flex or bend in any one particular direction.
  • [0057]
    FIG. 3B illustrates another variation where the sheath 102 includes an outer layer 126 and a lubricious layer 128. However, in this variation the lubricious layer 128 also includes a corrugated surface 136. It is noted that any combination of the sheath 102 and shaft 104 may have a corrugated surface.
  • [0058]
    FIG. 3C illustrates yet another aspect of construction of a sheath 102 for use with the present device. In this variation, the sheath 102 includes a multi-layer construction having an outer layer 126, one or more middle layers 138. The middle layers 138 may be selected to have properties that transition between the outer layer properties and the lubricious layer properties, and improve the bonding between inner and outer layer. Alternatively, the middle layer 138 may be selected to aid in the column strength of the device. An example of the middle layer includes Plexar PX 306, 3060, and/or 3080.
  • [0059]
    FIG. 3D depicts a variation of a shaft 104 for use with the devices described herein where the shaft outer surface comprises a lubricious layer 140. As illustrated, the shaft outer surface may also optionally have a corrugated surface 130. FIGS. 3E-3G illustrate additional variations of corrugated surfaces. As shown in FIG. 3E and 3F, either or both the sheath 102 and the shaft 104 may have corrugated surfaces that are formed by interrupting the surface. Naturally, different shapes and configurations may be otherwise constructed. FIG. 3G illustrates a variation where the sheath 102 comprises protrusions or spacer 142 to separate the surfaces of the sheath/shaft.
  • [0060]
    FIGS. 4A-4D illustrate yet another feature that may be incorporated with any of the subject devices. FIG. 4A illustrates an example of an alignment component 150. In this variation, the alignment component 150 includes a plurality of seats 152 that nest electrode arms (not shown). As discussed herein, the seats 152 allow for improved control of the angular spacing of the arms. Moreover, the seats 152 permits design of a device in which the flexure length of each of the arms of a basket type device is uniform (even if the tolerance of each arm varies). Though the alignment component 150 is shown as having four seats 152, any number of seats may be employed.
  • [0061]
    The alignment component 150 also includes a stop 154. The stop 154 acts as a reference guide for placement of the arms as discussed below. In this variation, the stop 154 is formed from a surface of an end portion 158. This end portion 158 is typically used to secure the alignment component 150 to (or within) the sheath/shaft of the device. The alignment component 150 may optionally include a through hole or lumen 156.
  • [0062]
    FIG. 4B illustrates another variation of an alignment component 152. This variation is similar to the variation shown in FIG. 4A, with the difference being the length of the end portion 158. The smaller end portion 158 may optionally be employed when the component 150 is used at the distal end of the device. In such a case, the component 158 may not be attached to the sheath or shaft. In addition, the end portion 158 may optionally be rounded, for example, to minimize tissue trauma that may be caused by the end of the device.
  • [0063]
    The alignment components 150 of the present invention may be fabricated from a variety of polymers (such as nylon or any other polymer commonly used in medical devices), either by machining, molding, or by cutting an extruded profile to length. One feature of this design is electrical isolation between the legs, which may also be obtained using a variation of the invention that employs a ceramic material for the alignment component. However, in one variation of the invention, an alignment component may be fabricated from a conductive material (e.g., stainless steel, polymer loaded with conductive material, or metallized ceramic) so that it provides electrical conductivity between adjacent electrode legs. In such a case, a power supply may be coupled to the alignment component, which then electrically couples all of the legs placed in contact with that component. The legs may be attached to the conductive alignment component with conductive adhesive, or by soldering or welding the legs to the alignment component. This does not preclude the legs and alignment component form being formed from one piece of metal.
  • [0064]
    Devices of the present invention may have one or more alignment components. Typically the alignment components are of the same size and/or the angular spacing of the seats is the same. However, variations may require alignment components of different sizes and/or different angular spacing. Another variation of the invention is to have the seats at an angle relative to the axis of the device, so as to form a helically shaped energy delivery element.
  • [0065]
    FIG. 4C illustrates another variation of an alignment component 150. In this variation, the alignment component 150 includes four seats 152. This variation includes an alignment stop 154 that protrudes from the surface of the component 150. In addition, the end portion 158 of the alignment component 150 is also of a cross section that may improve strength of the connection between the component and the sheath/shaft. In this case, the end portion 158 allows for crimping of the sheath/shaft. Optionally as shown, radial protrusions 178 at the right of the end portion 158 may be included to allow heat bonding of the alignment component to the shaft. In this case, the shaft may be a polymer with a melting temperature lower than that of the alignment component. When constrained to be coaxial, heat, and if necessary axial pressure, may be applied to join the two components.
  • [0066]
    FIG. 4D illustrates the protrusion-type stop 154 that retains a notch 162 of the electrode leg 160. This mode of securing the electrode leg 160 provides a “redundant-type” joint. In one example, the leg 160 is secured to the alignment component 150 using a sleeve (not shown) placed over both the leg 160 and alignment component 150 with or without the use of an adhesive within the sleeve. The notch 162 in the leg 160 is placed around the protrusion-type-stop 154. As a result, the notch-stop interface prevents the leg from being pulled from the device and is especially useful to prevent the proximal or near ends of the legs from separating from the device. It is noted that this safety feature is especially important when considering that if the proximal/near ends of the legs separate and hook on the anatomical passage, it may be difficult or impossible to remove the device from the passage. Such a failure may require significant medical intervention.
  • [0067]
    FIG. 4E illustrates one example of a leg 160 affixed to near/proximal and far/distal alignment components 144, 146. As shown, the leg 160 may have an insulated portion 164 and an exposed portion 166 that form electrodes. The near and far ends of the leg 160 are secured to respective alignment components 144, 146. In this example, sleeves 168 and 170 cover the leg and alignment component. As noted above, one or both of the alignment components may be electrically conductive to provide power to the electrodes. Furthermore, adhesive (e.g., cyanoacrylate, UV-cured acrylic, epoxy, or any such adhesive) may also be used to secure the leg to the components.
  • [0068]
    Additionally, the alignment components may be designed such that the sleeves may be press or snap fit onto the alignment components, eliminating the need for adhesively bonding the sleeves to the alignment components. FIG. 4F illustrates a perspective view of an end portion of an alignment component 150 having one or more slots 186 to create end portion segments 184. The slots 186 permit deflection of the end portion segments 184 to allow sliding of a sleeve or hypotube (either a near or far sleeve 168 or 170) over the end portion. FIG. 4G shows a cross sectional view of the component 150 of FIG. 4F. As shown, once advanced over the end portion segment 184, the sleeve or hypotube becomes secured to the component 150. To lock the sleeve in place, an insert or wire member 124 (not shown) is placed in the through hole or lumen 156. The insert or wire member prevents inward deflection of the end portion segments 184 thereby ensuring that the sleeve or hypotube remains secured to the component 150.
  • [0069]
    FIG. 5A shows a cross sectional view of two legs 160 attached to alignment components 144, 146. The sheath and shaft have been omitted for clarity. The flexure length 164 of the leg 160 is defined as the length between the alignment components 144, 146 over which the leg may flex when the proximal and distal ends are moved closer to one another. As noted above, the alignment components permit the flexure length 164 of the legs 160 to be uniform even if the leg lengths vary. The flexure length 164 is essentially set by the longest leg, the shorter legs may float between the stops 154 of the alignment components 144, 146. As an additional measure to prevent the legs 160 from inverting, the lengths of the sleeves 168 and 170 may be selected to be less than the length of the respective alignment components 144, 146 (as shown in the figure). The tendency of the leg to deflect outward can be improved by selecting the sleeve length as such. When the legs 160 expand they are supported by their respective seat on the interior side but unsupported on outer side. In yet another variation, the the seats can slant to predispose the arms to deflect in a desired direction. For example, as shown in FIG. 5C, the seats 152 can slant as shown to predispose the legs 160 to outward deflection. Such a construction can be accomplished by machining or by drafting a molded part in the direction of the catheter axis. As shown in FIG. 5D, the leg can have a slight bend or shape that predisposes the legs to bow outward.
  • [0070]
    FIG. 5B illustrates the variation of FIG. 5A in an expanded state. As shown, the device may have a wire 124 or other similar member that permits movement of the far alignment component 146 relative to the near alignment component 144. As noted herein, the wire 124 may be electrically conductive to provide power to electrodes on the device. FIG. 5B also illustrates a ball tip 148 at the end of the device. The ball tip 148 may serve as a means to secure the wire 124 as well as providing an atraumatic tip for the device.
  • [0071]
    Variations of the wire 124 may include a braided or coiled wire. The wire may be polymer coated or otherwise treated to electrically insulate or increase lubricity for easier movement within the device.
  • [0072]
    To expand the energy transfer element 108, the wire 124 may be affixed to a handle 106 and actuated with a slide mechanism 114 (as shown in FIG. 2A.) In an alternative design, the wire 124 may be affixed between the handle 106 and the distal end of the energy transfer element 108. In such a case, the slide mechanism 114 may be affixed to the shaft 104. Movement of the slide mechanism 114 causes expansion of the element 108 as the shaft causes movement of the proximal end of the energy transfer element (being fixed to the shaft) relative to the distal end of the energy transfer element (being fixed to the wire 124. In an additional variation, movement of the slide 114 may have two outcomes: 1) advancing the energy transfer element out of the sheath; and 2) subsequently expanding the energy transfer element. Such constructions are disclosed in U.S. patent application Ser. No. 09/436,455 filed Nov. 8, 1999 the entirety of which is incorporated by reference herein.
  • [0073]
    FIG. 6A illustrates a variation of an energy transfer element 108 in which the legs 160 have a predetermined shape. This shape may be selected as required for the particular application. As shown, the predetermined shape provides a certain length of the electrode 166 that may be useful for treatment of a long section of tissue.
  • [0074]
    FIG. 6B illustrates another variation of the energy transfer element 108. In this variation, the legs 160 extend out of openings 180 in the sheath 102 (in other variations, the legs may extend out of openings in the shaft). Accordingly, the alignment components and other parts of the device would be located within the sheath 102.
  • [0075]
    FIG. 6C illustrates yet another variation of an energy transfer element 108. In this variation, the basket is connected at a proximal end and opened at a distal end. The electrode legs 160 only have a single alignment component 150. The conductive member (or wire) may be located within the shaft 104. In this variation, advancement of the energy transfer element 108 out of the sheath 102 causes expansion of the element. The energy transfer elements may be predisposed or spring loaded to bow outward when advanced from the sheath.
  • [0076]
    FIG. 7A illustrates an example of a leg 160 with an energy element 180 coiled around the leg 160. In this example, the energy element 182 uses conductive heating and comprises a resistance heating element coiled around the leg 160. FIG. 7B illustrates a variation of the invention having an RF electrode attached to the basket leg 160. The RF electrode may be attached to the basket leg 160 via the use of a fastener. For example, the electrode may be attached via the use of a heat shrink fastener, (e.g., polymeric material such as PET or polyethylene tubing). Alternatively, as discussed above, the entire leg may be a conductive medium where a non-conductive coating insulates the majority of the leg leaving the electrode portion uninsulated. Further examples of energy transfer element configurations include paired bipolar electrodes, where the pairs are leg to leg or within each leg, and large matrices of paired electrodes affixed to a variety of expanding members (balloons, mechanisms, etc.)
  • [0077]
    FIG. 7C illustrates a variation of the invention having thermocouple leads 172 attached to an electrode 166 or leg of the device. The leads may be soldered, welded, or otherwise attached. This variation of the invention shows both leads 172 of the thermocouple 174 attached in electrical communication to a leg 160 at separate joints (or the leads may be separated but the solder on each connection actually flows together). In this case, the temperature sensor is at the surface of the leg. This variation provides a safety measure in case either joint becomes detached, the circuit will be open and the thermocouple 174 stops reading temperature. Such a condition may be monitored via the power supply and allow a safe shutdown of the system.
  • [0078]
    By spacing the leads of the thermocouple closely together to minimize temperature gradients in the energy transfer element between the thermocouple leads, thermoelectric voltage generated within the energy transfer element does not compromise the accuracy of the measurement. The leads may be spaced as close together as possible while still maintaining a gap so as to form an intrinsic junction with the energy transfer element. In another variation of the device, the thermocouple leads may be spaced anywhere along the tissue contacting region of the energy transfer element. Alternatively, or in combination, the leads may be spaced along the portion of an electrode that remains substantially straight. The intrinsic junction also provides a more accurate way of measuring surface temperature of the energy transfer element, as it minimizes the conduction error associated with an extrinsic junction adhered to the device.
  • [0079]
    The thermocouple leads may be attached to an interior of the leg or electrode. Such a configuration protects the thermocouple as the device expands against tissue and protects the tissue from potential trauma. The device may also include both of the thermocouple leads as having the same joint.
  • [0080]
    The devices of the present invention may use a variety of temperature sensing elements (a thermocouple being just one example, others include, infrared sensors, thermistors, resistance temperature detectors (RTDs), or any other component capable of detecting temperatures or changes in temperature). The temperature detecting elements may be placed on a single leg, on multiple legs or on all of the legs.
  • [0081]
    The present invention may also incorporate a junction that adjusts for misalignment between the branching airways or other body passages. This junction may be employed in addition to the other features described herein. FIG. 8A illustrates a device 100 having such a junction 176 allowing alignment of the device to closely match the alignment of the airway. It is noted that the present feature also benefits those cases in which the pathway and target site are offset as opposed to having an angular difference.
  • [0082]
    The junction 176 helps to eliminate the need for alignment of the axis of the active element 108 with the remainder of the device in order to provide substantially even tissue contact. The junction may be a joint, a flexure or equivalent means. A non-exhaustive listing of examples is provided below.
  • [0083]
    The legs 160 of the energy transfer element may have various shapes. For example, the shapes may be round, rounded or polygonal in cross section. Additionally, each leg may change cross section along its axis, providing for, for example, electrodes that are smaller or larger in cross section that the distal and proximal portions of each leg. This would provide a variety of energy delivery characteristics and bending profiles, allowing the design to be improved such that longer or wider electrode configurations can be employed. For example, as shown in FIG. 7D, if the cross-sectional thickness of the electrode portion 166 of the leg 160 is greater than the cross-sectional thickness of the distal and proximal portions of the leg, the leg would be predisposed to bow outward in the distal and proximal sections, while remaining flatter in the electrode area of the leg, potentially providing improved tissue contact.
  • [0084]
    As for the action the junction enables, it allows the distal end of the device to self-align with the cavity or passageway to be treated, irrespective of the alignment of the access passageway. FIG. 8A illustrates an example of where the access passageway and passageway to be treated are misaligned by an angle α. In the example shown in FIG. 8B, the misalignment angle α is greater than the angle illustrated in FIG. 8A. Yet, the energy transfer element 108 of the treatment device 100 remains substantially aligned with the target area.
  • [0085]
    FIGS. 8C and 8D illustrate an additional variation of the junction 176. In this variation the junction 176 may be reinforced with a reinforcing member 230. The reinforcing member may have some degree of flexibility to navigate the tortuous anatomy, but the flexibility will be less than the junction 176. As shown in FIG. 8C, the reinforcing member 230 maintains the device shaft 104 in an aligned position, preferably for insertion, removal, and or navigation of the device. When desired, the reinforcing member 230 may be removed from the junction 176 as illustrated in FIG. 8D. Accordingly, upon removal, the device is free to flex or orientate as desired. Furthermore, the reinforcing member may be reinserted within the junction 176 when repositioning or removing the device from the target site. In additional variations, it is contemplated that the reinforcing member may be placed external to the device/junction.
  • [0086]
    FIGS. 9A-9I illustrate additional junctions for use in the devices described herein. As for these examples, FIG. 9A illustrates a junction 176 in the form of a plurality of turns or coils 200 of a spring. The coil offers a flexure with 3-dimensional freedom allowing realignment of the active end of the subject device in any direction. Of course, a simple hinge or universal joint may also be employed.
  • [0087]
    The length of the junction (whether a spring junction or some other structure) may vary. Its length may depend on the overall system diameter. It may also depend on the degree of compliance desired. For example, with a longer effective junction length (made by extending the coil with additional turns), the junction becomes less rigid or more “floppy”.
  • [0088]
    In any case, it may be desired that the junction has substantially the same diameter of the device structure adjacent the junction. In this way, a more atraumatic system can be provided. In this respect, it may also be desired to encapsulate the junction with a sleeve or covering if they include open or openable structures. Junction 176 shown in FIGS. 8A and 8B is illustrated as being covered. A covering can help avoid contaminating the joint with body fluid or debris which could compromise junction function.
  • [0089]
    Some of the junctions are inherently protected. Junction 176 shown in FIG. 9B comprises a polymer plug 220 or a section of polymer having a different flexibility or durometer than adjacent sections. When a separate piece of polymer is to be employed, it can be chemically, adhesively, or heat welded to adjacent structure; when the junction is formed integrally, this may be accomplished by selective vulcanizing, or reinforcement (even with a braid or by other means of forming a composite structure). Generally, it is noted that any connection of pieces or construction provided may be produced by methods known by those with skill in the art.
  • [0090]
    As for junction 176 shown in FIG. 9C, it is formed by removing sections of material from the body of the device. Openings 218 formed at the junction may be left empty, covered or filled with a more compliant material. FIG. 9D also shows a junction 176 in which openings are provided to provide increased flexibility. Here, openings 218 are offset from each other to form a sort of flexible universal joint. In either junction variation shown in FIG. 9C or 9D, the size, number shape, etc. of the opening may vary or be tuned as desired.
  • [0091]
    FIG. 9E shows a junction 176 in the form of a bellows comprising plurality of pleats 216. Here too, the number of pleats, etc. may be varied to achieve desirable performance.
  • [0092]
    Junction 176 in FIG. 9F shows a true “joint” configuration. In this case, it is a universal joint provided by ball 204 and socket 206. These elements may be held together by a tie wire 208, possibly with caps 210. Other configurations are possible as well.
  • [0093]
    FIG. 9G illustrates a junction 176 in the form of a reduced diameter section 202. This variation offers greater flexibility by virtue of its decreased moment of inertia at the junction. While section 202 is integrally formed, the related junction 176 in FIG. 9H is formed from a hypotube or wire 212 having an exposed junction section 214 on the shaft 104. Variations of the invention will permit a junction having a reduced bending moment of inertia section as compared to the remainder of the device and/or shaft of the device. Reducing the bending moment of inertia may be accomplished in any number of ways. For example, there could be an area of reduced diameter, a section of material having a lower modulus, a section having a different shape, a flexible joint structure, etc. It should be noted that there are many additional ways to reduce the bending moment that will be readily apparent to those skilled in the art viewing the invention disclosed herein.
  • [0094]
    Yet another junction example is provided in FIG. 9I. Here junction 176 comprises a plurality of wires 222, 224, 226. In one variation, the wires simply offer increased flexibility of the junction. In another variation, the wires serve as an “active” or “dynamic” junction. The wires may be adjusted relative to one another to physically steer the distal end of the device. This junction may be manipulated manually with an appropriate user interface—especially one, like a joy-stick, that allows for full 3-dimensional or rotational freedom—or it may be controlled by automation using appropriate hardware and software controls. Of course, other “dynamic” junctions are possible as well.
  • [0095]
    FIG. 9J shows another joint configuration 176 employing an external sleeve 262 between sections of the shaft 104. A moveable wire 124 to actuate a distal basket or the like is also shown. The space between the wire and sleeve may be left open as shown, or filled in with a flexible polymer 264, such as low durometer urethane, a visco-elastic material, etc. Though not necessary, providing an internal member may improve system pushability. The sleeve itself will typically be a polymeric sleeve. It may be heat-shrink material such as PET tubing; it may be integrally formed with either catheter body portion and press fit or slip fit and glued over other etc.
  • [0096]
    Another variation of the junctions includes junctions variations where the shaft 104 is “floppy” (i.e., without sufficient column strength for the device to be pushable for navigation). In FIG. 10A, a tether 232 connects energy transfer element 108 to the shaft 104 of the device 100. The tether may simply comprise a flexible wire or cable, it may comprise a plurality of links, etc. The tether variation of the invention also accommodates relative motion between the device and the body (e.g., tidal motion of breathing, other muscle contractions, etc.) The tether permits the device to move relative to its intended treatment location unless the user desires and uses the tether or the sheath to pull the device back or drive it forward. The tether may have an alignment component (not illustrated) at the near end of the energy transfer element 108.
  • [0097]
    To navigate such a device to a treatment site, the energy transfer element 108 and tether 232 may be next to or within the sheath 102. In this manner, the column strength provided by the sheath allows for advancement of the active member within the subject anatomy.
  • [0098]
    The same action is required to navigate the device shown in FIG. 10B. What differs in this variation of the invention, however, is that the “tether” is actually a continuation of a highly flexible shaft 104. In this case, the shaft 104 of the device is shown with a thicker or reinforced wall. In such a device, the shaft carries the compressive loads on the device back to its distal end.
  • [0099]
    Like the device in FIG. 10B, the devices in FIGS. 10C and 10D have highly flexible shafts 104. However, instead of a stiffening external sheath, the device may employ a stiffening obturator 230 within a lumen of the shaft 104. As shown in FIG. 10C, when the obturator 230 fills the lumen, the device is relatively straight or stiff. When the shaft is withdrawn as shown in FIG. 10D, the distal end of the device is “floppy” or easily conformable to the subject anatomy. With the shaft advanced substantially to the end of the device, it offers ease of navigation; when withdrawn, it offers a compliant section according to an aspect of the present invention.
  • [0100]
    FIGS. 11A-11C illustrate yet another aspect of the invention in which a treatment device is equipped with an illumination source 242. As noted above, the illumination source 242 may be configured to provide additional light when the device is used without a scope or to supplement the illumination of the scope. Variations of the invention may include devices having one or more illumination sources 242 that are coupled to an illumination supply 240 that generates the light energy externally to the device (e.g., via a fiber or other type of light conductor). Alternatively, or in combination, the illumination source 242 may generate the light at the distal portion of the device (e.g., via a light emitting diode, etc). It should be noted that although FIG. 11, depicts the illumination supply 240 as being separate from the controller and energy generator, the illumination supply 240 may be integrated into the controller or energy generator.
  • [0101]
    FIG. 11A illustrates a variation of a system according to the present invention as shown in FIG. 2A above, with the addition of an illumination supply 240 and a device with one or more illumination sources 242. As noted above, a separate illumination supply 240 is optional as the illumination supply 240 may be incorporated with other components of the system (e.g., device controller, generator, or other).
  • [0102]
    FIG. 11B shows a variation of a device as shown in FIG. 8A. However, in this variation, the device includes an illumination source 242. As shown, the illumination source 242 may be located on a tip 122 of the device, on the shaft 104, on the sheath 102, on the energy transfer element (as shown in FIG. 11C) or in any combination thereof. Although not illustrated, the illumination source may be placed on or adjacent to a center wire 124 of the basket member 108. For example, an LED may be placed on the wire, or an optical fiber may be placed adjacent to or wrapped around the wire 124. Alternatively, a filament or other similar type component may be affixed to the wire in a similar manner, where the filament generates light of a particular wavelength.
  • [0103]
    FIG. 11C illustrates just one example of a basket leg variation as shown in FIG. 4E above, with the addition of an illumination source 242 that is placed on the leg. In each of the above cases, the illumination source 242 may be an end of a fiber type element that extends through the device and terminates at the illumination source 242 (alternatively or in combination, this variation may include a lens or cover at the termination of the fiber). The illumination source may also comprise a component that emits energy or light (such as a light emitting diode).
  • [0104]
    It is further contemplated that the illumination source 242 may be placed on a single side of the device or may be placed such that all walls of the airway are illuminated.
  • [0105]
    It is noted that variations of the device may include a single illumination source 242 or multiple illumination sources 242. The illumination source(s) 242 may be configured to provide a single or multiple wavelength of light depending upon the particular application. For example, the device may be configured to provide illumination that is visible light, or white light. The illumination can be a single visible color such as red, green, blue, yellow, or a combination. The illumination may be a non-visible wavelength that is made visible by some type of filter or other such means on the scope or viewing monitor for the scope.
  • [0106]
    Variations of the invention include aiming or positioning the illumination source rearward to aid in light collection by the scope, use of a flex circuit to carry LED and have traces, use of LED lens cap as an atraumatic distal tip.
  • [0107]
    In addition, certain wavelengths may afford separation from red and orange (e.g., 590 nm, 570 nm, 470 nm or yellow, green, and blue. These colors may offer better distinction when used in airways. In variations of the invention using light emitting diodes (LEDS), the may be commercially available in surface mount configurations having a size that is suited for a device that must fit in a 2 mm working channel. See for example, www.kingbright-led.com, surface mount LED package, APHH1005.
  • [0108]
    At the very least, LED may make it easier for the practitioner to identify treated areas within the airway, such as tissue that is blanched or otherwise marked by the application of energy. In these cases, the reflectance of this tissue may be different than surrounding areas.
  • [0109]
    The invention may also be used with polarizing filters or polarizing fibers to differentiate treated from untreated tissue. Use of circularly polarized filters may be preferred in such a case to eliminate the need for rotation of the filters. In yet another approach the illumination supply/source may use coherent sources of light such as solid state or optical lasers. In the case of a solid state laser, the laser source may actually be placed on the distal end of the device rather than being transmitted via a fiber.
  • [0110]
    Furthermore, use digital (electronic) filtering of the image from CCD chip mounted at the end of the bronchoscope may permit filtering for desirable wavelengths and/or the image could be amplified to enable discernment. In addition, so long as long the system delivers light containing a broad spectrum of wavelengths, electronic or manual filtering may allow for filtering out any undesirable components. In additional variations, a filter or filters may be placed on the end of the device.
  • [0111]
    As for other details of the present invention, materials and manufacturing techniques may be employed as within the level of those with skill in the relevant art. The same may hold true with respect to method-based aspects of the invention in terms of additional acts a commonly or logically employed. In addition, though the invention has been described in reference to several examples, optionally incorporating various features, the invention is not to be limited to that which is described or indicated as contemplated with respect to each variation of the invention.
  • [0112]
    Various changes may be made to the invention described and equivalents (whether recited herein or not included for the sake of some brevity) may be substituted without departing from the true spirit and scope of the invention.
  • [0113]
    It is contemplated that, where possible, combinations of aspects of each embodiment or combinations of the embodiments themselves are within the scope of the invention.
  • [0114]
    Reference to a singular item, includes the possibility that there are plural of the same items present. More specifically, as used herein and in the appended claims, the singular forms “a,” “and,” “said,” and “the” include plural referents unless the context clearly dictates otherwise.
Citas de patentes
Patente citada Fecha de presentación Fecha de publicación Solicitante Título
US2072346 *4 Oct 19342 Mar 1937Ward R SmithDrainage tube
US3568659 *24 Sep 19689 Mar 1971Karnegis James NDisposable percutaneous intracardiac pump and method of pumping blood
US4565200 *4 May 198221 Ene 1986Cosman Eric RUniversal lesion and recording electrode system
US4567882 *10 Dic 19844 Feb 1986Vanderbilt UniversityMethod for locating the illuminated tip of an endotracheal tube
US4584998 *11 Sep 198129 Abr 1986Mallinckrodt, Inc.Multi-purpose tracheal tube
US4643186 *30 Oct 198517 Feb 1987Rca CorporationPercutaneous transluminal microwave catheter angioplasty
US4799479 *8 Ene 198724 Ene 1989The Beth Israel Hospital AssociationMethod and apparatus for angioplasty
US4802492 *11 Mar 19877 Feb 1989National Jewish Center For Immunology And Respiratory MedicineMethod for determining respiratory function
US5010892 *4 May 198830 Abr 1991Triangle Research And Development Corp.Body lumen measuring instrument
US5084044 *14 Jul 198928 Ene 1992Ciron CorporationApparatus for endometrial ablation and method of using same
US5087153 *23 Ago 198911 Feb 1992Arnco CorporationInternally spiraled duct and method of installation
US5096916 *7 May 199017 Mar 1992Aegis Technology, Inc.Treatment of chronic obstructive pulmonary disease (copd) by inhalation of an imidazoline
US5100388 *25 May 199031 Mar 1992Interventional Thermodynamics, Inc.Method and device for thermal ablation of hollow body organs
US5100423 *21 Ago 199031 Mar 1992Medical Engineering & Development Institute, Inc.Ablation catheter
US5103804 *3 Jul 199014 Abr 1992Boston Scientific CorporationExpandable tip hemostatic probes and the like
US5106360 *11 Feb 199121 Abr 1992Olympus Optical Co., Ltd.Thermotherapeutic apparatus
US5188602 *8 Jun 199223 Feb 1993Interventional Thermodynamics, Inc.Method and device for delivering heat to hollow body organs
US5191883 *22 May 19909 Mar 1993Prutech Research And Development Partnership IiDevice for heating tissue in a patient's body
US5281218 *5 Jun 199225 Ene 1994Cardiac Pathways CorporationCatheter having needle electrode for radiofrequency ablation
US5292331 *24 Ago 19898 Mar 1994Applied Vascular Engineering, Inc.Endovascular support device
US5293569 *12 Sep 19918 Mar 1994Canon Kabushiki KaishaMagneto-optical recording/reproducing apparatus including an optical head with an optical element having a plurality of prisms
US5383917 *5 Jul 199124 Ene 1995Jawahar M. DesaiDevice and method for multi-phase radio-frequency ablation
US5384880 *3 Dic 199324 Ene 1995Alcatel Na Cable Systems, Inc.Dielectric ribbon optical fiber cable
US5394287 *29 Ene 199328 Feb 1995Mitsubishi Denki Kabushiki KaishaOvercurrent protective device for power device
US5396887 *23 Sep 199314 Mar 1995Cardiac Pathways CorporationApparatus and method for detecting contact pressure
US5400783 *12 Oct 199328 Mar 1995Cardiac Pathways CorporationEndocardial mapping apparatus with rotatable arm and method
US5409469 *4 Nov 199325 Abr 1995Medtronic, Inc.Introducer system having kink resistant splittable sheath
US5496271 *16 Jun 19935 Mar 1996American Medical Systems, Inc.Combined hyperthermia and dilation catheter
US5496311 *2 May 19945 Mar 1996Boston Scientific CorporationPhysiologic low stress angioplasty
US5500011 *4 Nov 199419 Mar 1996Desai; Jawahar M.Catheter for mapping and ablation and method therefor
US5505728 *9 Ene 19959 Abr 1996Ellman; Alan G.Electrosurgical stripping electrode for palatopharynx tissue
US5505730 *24 Jun 19949 Abr 1996Stuart D. EdwardsThin layer ablation apparatus
US5507287 *27 Abr 199516 Abr 1996Xillix Technologies CorporationEndoscopic imaging system for diseased tissue
US5509411 *27 Ene 199423 Abr 1996Cardima, Inc.Intravascular sensing device
US5509419 *16 Dic 199323 Abr 1996Ep Technologies, Inc.Cardiac mapping and ablation systems
US5595183 *17 Feb 199521 Ene 1997Ep Technologies, Inc.Systems and methods for examining heart tissue employing multiple electrode structures and roving electrodes
US5598848 *31 Mar 19944 Feb 1997Ep Technologies, Inc.Systems and methods for positioning multiple electrode structures in electrical contact with the myocardium
US5599345 *24 Ago 19944 Feb 1997Zomed International, Inc.RF treatment apparatus
US5601088 *17 Feb 199511 Feb 1997Ep Technologies, Inc.Systems and methods for filtering artifacts from composite signals
US5605157 *17 Feb 199525 Feb 1997Ep Technologies, Inc.Systems and methods for filtering signals derived from biological events
US5607419 *24 Abr 19954 Mar 1997Angiomedics Ii Inc.Method and apparatus for treating vessel wall with UV radiation following angioplasty
US5607462 *7 Jul 19944 Mar 1997Cardiac Pathways CorporationCatheter assembly, catheter and multi-catheter introducer for use therewith
US5620438 *20 Abr 199515 Abr 1997Angiomedics Ii IncorporatedMethod and apparatus for treating vascular tissue following angioplasty to minimize restenosis
US5707352 *7 Jun 199513 Ene 1998Alliance Pharmaceutical Corp.Pulmonary delivery of therapeutic agent
US5722401 *13 Nov 19953 Mar 1998Cardiac Pathways CorporationEndocardial mapping and/or ablation catheter probe
US5722403 *28 Oct 19963 Mar 1998Ep Technologies, Inc.Systems and methods using a porous electrode for ablating and visualizing interior tissue regions
US5722416 *17 Feb 19953 Mar 1998Ep Technologies, Inc.Systems and methods for analyzing biopotential morphologies in heart tissue to locate potential ablation sites
US5725525 *16 Ene 199610 Mar 1998Ep Technologies, Inc.Multiple electrode support structures with integral hub and spline elements
US5728094 *3 May 199617 Mar 1998Somnus Medical Technologies, Inc.Method and apparatus for treatment of air way obstructions
US5730128 *24 Sep 199624 Mar 1998Cardiac Pathways CorporationEndocardial mapping apparatus
US5730726 *4 Mar 199624 Mar 1998Klingenstein; Ralph JamesApparatus and method for removing fecal impaction
US5730741 *7 Feb 199724 Mar 1998Eclipse Surgical Technologies, Inc.Guided spiral catheter
US5855577 *7 Feb 19975 Ene 1999Eclipse Surgical Technologies, Inc.Bow shaped catheter
US5860974 *11 Feb 199719 Ene 1999Boston Scientific CorporationHeart ablation catheter with expandable electrode and method of coupling energy to an electrode on a catheter shaft
US5863291 *8 Abr 199626 Ene 1999Cardima, Inc.Linear ablation assembly
US5868740 *24 Mar 19959 Feb 1999Board Of Regents-Univ Of NebraskaMethod for volumetric tissue ablation
US5871443 *14 Nov 199616 Feb 1999Ep Technologies, Inc.Cardiac mapping and ablation systems
US5871523 *12 Ago 199616 Feb 1999Ep Technologies, Inc.Helically wound radio-frequency emitting electrodes for creating lesions in body tissue
US5873865 *7 Feb 199723 Feb 1999Eclipse Surgical Technologies, Inc.Spiral catheter with multiple guide holes
US5876399 *28 May 19972 Mar 1999Irvine Biomedical, Inc.Catheter system and methods thereof
US5881727 *4 Ene 199616 Mar 1999Ep Technologies, Inc.Integrated cardiac mapping and ablation probe
US5882346 *15 Jul 199616 Mar 1999Cardiac Pathways CorporationShapable catheter using exchangeable core and method of use
US6009877 *19 Feb 19984 Ene 2000Edwards; Stuart D.Method for treating a sphincter
US6010500 *21 Jul 19974 Ene 2000Cardiac Pathways CorporationTelescoping apparatus and method for linear lesion ablation
US6014579 *21 Jul 199711 Ene 2000Cardiac Pathways Corp.Endocardial mapping catheter with movable electrode
US6016437 *21 Ago 199818 Ene 2000Irvine Biomedical, Inc.Catheter probe system with inflatable soft shafts
US6023638 *22 May 19988 Feb 2000Scimed Life Systems, Inc.System and method for conducting electrophysiological testing using high-voltage energy pulses to stun tissue
US6024740 *8 Jul 199715 Feb 2000The Regents Of The University Of CaliforniaCircumferential ablation device assembly
US6033397 *26 Sep 19967 Mar 2000Vnus Medical Technologies, Inc.Method and apparatus for treating esophageal varices
US6036687 *5 Mar 199614 Mar 2000Vnus Medical Technologies, Inc.Method and apparatus for treating venous insufficiency
US6039731 *29 Oct 199821 Mar 2000Engineering & Research Associates, Inc.Apparatus and method for determining the extent of ablation
US6179833 *24 Ago 199930 Ene 2001Engineering & Research Associates, Inc.Apparatus for thermal ablation
US6198970 *25 Ene 19996 Mar 2001Esd Limited Liability CompanyMethod and apparatus for treating oropharyngeal respiratory and oral motor neuromuscular disorders with electrical stimulation
US6200311 *20 Ene 199813 Mar 2001Eclipse Surgical Technologies, Inc.Minimally invasive TMR device
US6200332 *9 Jul 199913 Mar 2001Ceramoptec Industries, Inc.Device and method for underskin laser treatments
US6200333 *31 Dic 199813 Mar 2001Broncus Technologies, Inc.Bronchial stenter
US6338836 *28 Sep 199915 Ene 2002Siemens AktiengesellschaftAsthma analysis method employing hyperpolarized gas and magnetic resonance imaging
US6514246 *7 Jul 19984 Feb 2003Ep Technologies, Inc.Systems and methods for forming large lesions in body tissue using curvilinear electrode elements
US6526320 *16 May 200125 Feb 2003United States Surgical CorporationApparatus for thermal treatment of tissue
US6673068 *12 Abr 20006 Ene 2004Afx, Inc.Electrode arrangement for use in a medical instrument
US6692492 *28 Nov 200117 Feb 2004Cardiac Pacemaker, Inc.Dielectric-coated ablation electrode having a non-coated window with thermal sensors
US6699243 *19 Sep 20012 Mar 2004Curon Medical, Inc.Devices, systems and methods for treating tissue regions of the body
US6714822 *30 May 200230 Mar 2004Medtronic, Inc.Apparatus and method for expanding a stimulation lead body in situ
US6837888 *25 Feb 20024 Ene 2005Arthrocare CorporationElectrosurgical probe with movable return electrode and methods related thereto
US6840243 *18 Abr 200311 Ene 2005Emphasys Medical, Inc.Methods and devices for use in performing pulmonary procedures
US6849073 *24 Abr 20021 Feb 2005Medtronic, Inc.Apparatus and method for creating, maintaining, and controlling a virtual electrode used for the ablation of tissue
US6852091 *15 Abr 20028 Feb 2005Medtronic Vidamed, Inc.Medical probe device and method
US6852110 *1 Ago 20028 Feb 2005Solarant Medical, Inc.Needle deployment for temperature sensing from an electrode
US6866662 *23 Jul 200215 Mar 2005Biosense Webster, Inc.Ablation catheter having stabilizing array
US6869437 *13 Nov 200122 Mar 2005Cardica, Inc.Method and system for performing closed-chest bypass
US7163533 *20 Mar 200316 Ene 2007Angiodynamics, Inc.Vascular treatment device and method
US7186251 *25 Feb 20046 Mar 2007Cierra, Inc.Energy based devices and methods for treatment of patent foramen ovale
US20030036751 *30 May 200120 Feb 2003Anderson R. RoxApparatus and method for laser treatment with spectroscopic feedback
US20040031494 *13 Ago 200319 Feb 2004Broncus Technologies, Inc.Methods of treating asthma
US20050010270 *26 Mar 200413 Ene 2005Asthmatx, Inc.Method of treating airways in the lung
US20060062808 *30 Sep 200423 Mar 2006Asthmatx, Inc.Inactivation of smooth muscle tissue
US20090018538 *12 Jul 200715 Ene 2009Asthmatx, Inc.Systems and methods for delivering energy to passageways in a patient
US20090043301 *8 Ago 200812 Feb 2009Asthmatx, Inc.Monopolar energy delivery devices and methods for controlling current density in tissue
US20090069797 *8 Sep 200812 Mar 2009Asthmatx, Inc.Bipolar devices for modification of airways by transfer of energy
Otras citas
Referencia
1 *Everett et al, "Birefringence characterization of biological tissue by use of optical coherence tomography", Feb 1998, Optics Letters, Vol. 23; No. 3, pp. 228-230
2 *Thomsen et al, "Changes in Birefringence as Markers of Thermal Damage in Tissues", December 1989, IEEE Transactions on Biomedical Engineering, Vol. 36; No. 12, pp. 1174-1179
Citada por
Patente citante Fecha de presentación Fecha de publicación Solicitante Título
US783767917 Jul 200623 Nov 2010Asthmatx, Inc.Control system and process for application of energy to airway walls and other mediums
US785333125 May 200614 Dic 2010Asthmatx, Inc.Medical device with procedure improvement features
US785473417 Jul 200621 Dic 2010Asthmatx, Inc.Control system and process for application of energy to airway walls and other mediums
US792185511 Dic 200612 Abr 2011Asthmatx, Inc.Method for treating an asthma attack
US793164720 Oct 200626 Abr 2011Asthmatx, Inc.Method of delivering energy to a lung airway using markers
US79381231 Dic 200810 May 2011Asthmatx, Inc.Modification of airways by application of cryo energy
US794940729 Dic 200624 May 2011Asthmatx, Inc.Energy delivery devices and methods
US79925727 Nov 20069 Ago 2011Asthmatx, Inc.Methods of evaluating individuals having reversible obstructive pulmonary disease
US80881278 May 20093 Ene 2012Innovative Pulmonary Solutions, Inc.Systems, assemblies, and methods for treating a bronchial tree
US816197818 Mar 201024 Abr 2012Asthmatx, Inc.Methods for treating asthma by damaging nerve tissue
US81728271 Jun 20068 May 2012Innovative Pulmonary Solutions, Inc.Apparatus for treating asthma using neurotoxin
US818165623 Feb 200622 May 2012Asthmatx, Inc.Methods for treating airways
US822663826 Sep 201124 Jul 2012Innovative Pulmonary Solutions, Inc.Systems, assemblies, and methods for treating a bronchial tree
US823598312 Jul 20077 Ago 2012Asthmatx, Inc.Systems and methods for delivering energy to passageways in a patient
US82510704 Abr 200628 Ago 2012Asthmatx, Inc.Methods for treating airways
US825741322 Sep 20064 Sep 2012Asthmatx, Inc.Modification of airways by application of energy
US82670944 Dic 200818 Sep 2012Asthmatx, Inc.Modification of airways by application of ultrasound energy
US844381020 Jun 200621 May 2013Asthmatx, Inc.Methods of reducing mucus in airways
US845926824 Abr 201211 Jun 2013Asthmatx, Inc.Methods for treating airways
US846472328 Jun 201118 Jun 2013Asthmatx, Inc.Methods of evaluating individuals having reversible obstructive pulmonary disease
US846548625 Jul 201218 Jun 2013Asthmatx, Inc.Modification of airways by application of energy
US848066725 May 20069 Jul 2013Asthmatx, Inc.Medical device with procedure improvement features
US848383117 Feb 20099 Jul 2013Holaira, Inc.System and method for bronchial dilation
US848919214 Jun 201216 Jul 2013Holaira, Inc.System and method for bronchial dilation
US853429131 May 200617 Sep 2013Asthmatx, Inc.Methods of treating inflammation in airways
US858468122 Abr 201019 Nov 2013Asthmatx, Inc.Method for treating an asthma attack
US86407119 Dic 20104 Feb 2014Asthmatx, Inc.Method for treating an asthma attack
US873167218 Jun 201320 May 2014Holaira, Inc.System and method for bronchial dilation
US873336728 Mar 201327 May 2014Asthmatx, Inc.Methods of treating inflammation in airways
US874089528 Jun 20133 Jun 2014Holaira, Inc.Delivery devices with coolable energy emitting assemblies
US877794328 Jun 201315 Jul 2014Holaira, Inc.Delivery devices with coolable energy emitting assemblies
US880828020 Abr 201219 Ago 2014Holaira, Inc.Systems, assemblies, and methods for treating a bronchial tree
US882148920 Abr 20122 Sep 2014Holaira, Inc.Systems, assemblies, and methods for treating a bronchial tree
US888876911 Nov 201018 Nov 2014Asthmatx, Inc.Control system and process for application of energy to airway walls and other mediums
US891143911 Nov 201016 Dic 2014Holaira, Inc.Non-invasive and minimally invasive denervation methods and systems for performing the same
US892041325 May 200630 Dic 2014Asthmatx, Inc.Energy delivery devices and methods
US893228926 Sep 201113 Ene 2015Holaira, Inc.Delivery devices with coolable energy emitting assemblies
US894407120 Ago 20123 Feb 2015Asthmatx, Inc.Method for treating an asthma attack
US896150720 Abr 201224 Feb 2015Holaira, Inc.Systems, assemblies, and methods for treating a bronchial tree
US896150820 Abr 201224 Feb 2015Holaira, Inc.Systems, assemblies, and methods for treating a bronchial tree
US900519526 Sep 201114 Abr 2015Holaira, Inc.Delivery devices with coolable energy emitting assemblies
US901732428 Jun 201328 Abr 2015Holaira, Inc.Delivery devices with coolable energy emitting assemblies
US902756410 May 201312 May 2015Asthmatx, Inc.Method for treating a lung
US903397616 May 201319 May 2015Asthmatx, Inc.Modification of airways by application of energy
US912564330 Abr 20148 Sep 2015Holaira, Inc.System and method for bronchial dilation
US914932811 Nov 20106 Oct 2015Holaira, Inc.Systems, apparatuses, and methods for treating tissue and controlling stenosis
US927213231 Oct 20131 Mar 2016Boston Scientific Scimed, Inc.Medical device for treating airways and related methods of use
US92833745 Nov 201315 Mar 2016Boston Scientific Scimed, Inc.Devices and methods for delivering energy to body lumens
US93396185 Nov 201217 May 2016Holaira, Inc.Method and apparatus for controlling narrowing of at least one airway
US935802414 May 20137 Jun 2016Asthmatx, Inc.Methods for treating airways
US939893327 Dic 201326 Jul 2016Holaira, Inc.Methods for improving drug efficacy including a combination of drug administration and nerve modulation
US957261920 Ene 201621 Feb 2017Boston Scientific Scimed, Inc.Medical device for treating airways and related methods of use
US959208615 May 201314 Mar 2017Boston Scientific Scimed, Inc.Electrodes for tissue treatment
US964915327 Oct 201016 May 2017Holaira, Inc.Delivery devices with coolable energy emitting assemblies
US964915414 Nov 201416 May 2017Holaira, Inc.Non-invasive and minimally invasive denervation methods and systems for performing the same
US966880922 Ago 20126 Jun 2017Holaira, Inc.Systems, assemblies, and methods for treating a bronchial tree
US967541231 Oct 201413 Jun 2017Holaira, Inc.Delivery devices with coolable energy emitting assemblies
US977029316 May 201326 Sep 2017Boston Scientific Scimed, Inc.Systems and methods for treating tissue of a passageway within a body
US978933116 Oct 201317 Oct 2017Boston Scientific Scimed, Inc.Methods of treating a lung
US20060247619 *25 May 20062 Nov 2006Asthmatx, Inc.Medical device with procedure improvement features
US20090192508 *20 Feb 200930 Jul 2009Asthmatx, Inc.Modification of airways by application of mechanical energy
US20100160906 *17 Dic 200924 Jun 2010Asthmatx, Inc.Expandable energy delivery devices having flexible conductive elements and associated systems and methods
US20100179432 *9 Ene 200915 Jul 2010Boston Scientific Scimed, Inc.Systems and methods for making and using intravascular ultrasound systems with photo-acoustic imaging capabilities
US20100262079 *16 Mar 201014 Oct 2010Tyco Healthcare Group LpBendable veress needle assembly
US20110213236 *4 Feb 20111 Sep 2011Immunopath Profile, Inc.Therapeutic compositions, devices and methods for observing treated tissues
WO2010017403A2 *6 Ago 200911 Feb 2010Immunopath Profile, Inc.Therapeutic compositions, devices and methods for observing treated tissues
WO2010017403A3 *6 Ago 200927 May 2010Immunopath Profile, Inc.Therapeutic compositions, devices and methods for observing treated tissues
WO2014052199A120 Sep 20133 Abr 2014Boston Scientific Scimed, Inc.Systems and methods for controlling energy application
Clasificaciones
Clasificación de EE.UU.607/101, 600/473, 600/476
Clasificación internacionalA61F2/00, A61B6/00
Clasificación cooperativaA61B90/30, A61B2018/00267, A61B2018/00821, A61B18/02, A61B2018/00214, A61B2018/0022, A61B2018/00797, A61B2018/00791, A61B2018/00541, A61B18/1492, A61B18/08, A61N7/022
Clasificación europeaA61B18/14V
Eventos legales
FechaCódigoEventoDescripción
28 Dic 2006ASAssignment
Owner name: ASTHMATX, INC., CALIFORNIA
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:DANEK, CHRISTOPHER J.;KAPLAN, GARY S.;WIZEMAN, WILLIAM J.;AND OTHERS;REEL/FRAME:018690/0075;SIGNING DATES FROM 20060626 TO 20060706
28 Oct 2016ASAssignment
Owner name: BOSTON SCIENTIFIC SCIMED, INC., MINNESOTA
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:ASTHMATX, INC.;REEL/FRAME:040510/0149
Effective date: 20101026